Medroxyprogesterone Acetate Injection, Suspension
Product Images NDC 62756-090

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Medroxyprogesterone Acetate (NDC 62756-090). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Spl-medroxy-carton (Spl Medroxy Carton)

Carton label for MEDROXYPROGESTERONE ACETATE 150 mg/mL injectable suspension, USP for intramuscular use. The label shows it is a 1 mL single-dose vial, prescription only, distributed by Sun Pharmaceutical Industries, Inc. It includes storage instructions, ingredients, and the Sun Pharma logo. The NDC is 62756-090-40.*

FDA Label Image

Spl-medroxy-fig1 (Spl Medroxy Fig1)

A forest plot showing risk estimates for breast cancer in users of Medroxyprogesterone Acetate (DMPA). The chart displays odds ratios with 95% confidence intervals on a logarithmic scale from multiple studies by Lee et al. (1987), Paul et al. (1989), WHO (1991), Shapiro et al. (2000), and Li et al. (2012), including subgroups of all subjects and those with DMPA use ≥12 months. The x-axis represents odds ratio values, where values above 1 indicate increased risk.*

FDA Label Image

Spl-medroxy-label (Spl Medroxy Label)

Label for Medroxyprogesterone Acetate Injectable Suspension, USP 150 mg/mL, for intramuscular use only. The label indicates storage temperatures between 20° to 25°C (68° to 77°F). It is an Rx only, 1 mL single-dose vial. Manufactured by Sun Pharmaceutical Industries, Ltd., India, and distributed by Sun Pharmaceutical Industries, Inc., New Jersey.*

FDA Label Image

Spl-medroxy-pil (Spl Medroxy Pil)

An illustration showing relative effectiveness of various birth control methods by number of pregnancies per 100 women per year. Methods are categorized from fewer pregnancies (implants, injections, intrauterine devices, sterilization) to more pregnancies (no birth control), with intermediate methods including birth control pills, skin patch, vaginal ring, condoms, diaphragm, abstinence during fertile days, spermicide, and withdrawal.*

FDA Label Image

Spl-medroxy-structure (Spl Medroxy Structure)

Chemical structure of medroxyprogesterone acetate, depicting its molecular arrangement with labeled carbon, oxygen atoms, and methyl groups characteristic of this active ingredient.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.